GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merus Labs International Inc (NAS:MSLI) » Definitions » Market Cap

Merus Labs International (Merus Labs International) Market Cap : $152.23 Mil (As of Apr. 26, 2024)


View and export this data going back to 1996. Start your Free Trial

What is Merus Labs International Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Merus Labs International's share price for the quarter that ended in Mar. 2017 was $0.93. Merus Labs International's Shares Outstanding (EOP) for the quarter that ended in Mar. 2017 was 117.35 Mil. Therefore, Merus Labs International's market cap for the quarter that ended in Mar. 2017 was $109.13 Mil.

Merus Labs International's quarterly market cap declined from Sep. 2016 ($120.51 Mil) to Dec. 2016 ($102.09 Mil) but then increased from Dec. 2016 ($102.09 Mil) to Mar. 2017 ($109.13 Mil).

Merus Labs International's annual market cap increased from Sep. 2014 ($0.00 Mil) to Sep. 2015 ($131.97 Mil) but then declined from Sep. 2015 ($131.97 Mil) to Sep. 2016 ($120.51 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Merus Labs International's Enterprise Value for Today is $152.23 Mil.


Merus Labs International Market Cap Historical Data

The historical data trend for Merus Labs International's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merus Labs International Market Cap Chart

Merus Labs International Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 131.97 120.51

Merus Labs International Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 150.82 149.76 120.51 102.09 109.13

Competitive Comparison of Merus Labs International's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Merus Labs International's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merus Labs International's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merus Labs International's Market Cap distribution charts can be found below:

* The bar in red indicates where Merus Labs International's Market Cap falls into.



Merus Labs International Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Merus Labs International's Market Cap for the fiscal year that ended in Sep. 2016 is calculated as

Market Cap (A: Sep. 2016 )=Share Price (A: Sep. 2016 )*Shares Outstanding (EOP) (A: Sep. 2016 )
=$1.03*117
=$120.51

Merus Labs International's Market Cap for the quarter that ended in Mar. 2017 is calculated as

Market Cap (Q: Mar. 2017 )=Share Price (Q: Mar. 2017 )*Shares Outstanding (EOP) (Q: Mar. 2017 )
=$0.93*117.345
=$109.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merus Labs International  (NAS:MSLI) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Merus Labs International Market Cap Related Terms

Thank you for viewing the detailed overview of Merus Labs International's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Merus Labs International (Merus Labs International) Business Description

Traded in Other Exchanges
N/A
Address
Merus Labs International Inc was incorporated on October 1, 2012 in British Columbia. The Company is a specialty pharmaceutical company. It acquires prescription medicines in various categories which include on patent but at maturity stage of product life cycle; branded generics; under promoted products; Niche market pharmaceuticals; and products with annual sales below critical threshold for large pharma. The Company competes with multinational pharmaceutical development corporations to small, single product companies that may limit their activities to a particular therapeutic area or region or territory.

Merus Labs International (Merus Labs International) Headlines